Quality Standards & Compliance
Larissa Pharma's manufacturer audit process, GSP-compliant storage and batch-level traceability — prepared for regulatory dossiers and GMP inspection.
Credentials you can verify
Each certificate is held by the entity that operates the activity it covers. The images below are taken from the certificates themselves, and every original file can be downloaded for verification.
GDPLarissa PharmaGood Distribution Practice
GDP-compliant storage, transport and traceability across the entire distribution chain.
2881/GDP
Department of Health, Ho Chi Minh City
Issued 11/11/2024
Valid until 11/11/2027
View certificate (PDF)
GSPLarissa PharmaGood Storage Practice
Temperature and humidity controlled warehousing with dedicated functional zones at the head office site.
611/GCN-QLD
Drug Administration of Vietnam
Issued 04/05/2024
Harmonised with WHO GSP guidelines
View certificate (PDF)
ĐKKD DượcLarissa PharmaPharmaceutical Business Licence
Wholesale of medicines and medicinal materials.
ISO 15378:2017Kiến ViệtPrimary packaging materials for medicinal products
International standard for packaging in direct contact with medicines, held by affiliate Kiến Việt.
ISO 9001:2015Kiến ViệtQuality Management System
Supplying and printing pharmaceutical packaging materials under a certified quality management system.
Responsible pharmacist: Nguyễn Đan Thư, BPharm · Practice certificate No. 4257/HCM-CCHND
What we are licensed to distribute
The scope below is stated on pharmaceutical business licence No. 9770/ĐKKDD-HCM. Quality assurance teams can check it against the PDF in the section above.
Wholesale establishment for medicines and pharmaceutical starting materials
Product categoriesChemical medicines
Herbal medicinal products
Traditional medicines
Biologicals stored at ambient conditions
Pharmaceutical starting materials
Active ingredients, excipients and capsule shells — Larissa's core business.
- Combination medicines containing narcotic, psychotropic or precursor substances
- Toxic medicines and toxic starting materials
- Substances on the list restricted in certain industries and sectors
- β-lactam starting materials
β-lactam materials fall within the licensed scope and are stored in segregation to prevent cross-contamination of other product groups.
GSP-certified warehouse
Incoming goods, sampling, quarantine, storage and outbound staging are separated into dedicated, signed zones, each under controlled temperature and humidity, with entry control and gowning at the warehouse threshold.

Storage area
Temperature-controlled racking under GSP certificate No. 611/GCN-QLD.

Sampling room
Differential-pressure monitored.

Segregated storage
Kho 1, Kho 2 and Kho 3.

Outbound staging
Goods staged before dispatch.
Complete, batch by batch
The documents below accompany every batch, ready for regulatory dossiers and GMP inspection.
- 01
CoA
Certificate of Analysis
- 02
MSDS
Material Safety Data Sheet
- 03
CO
Certificate of Origin
- 04
CQ
Certificate of Quality
- 05
GMP
Manufacturer GMP certificate
- 06
DMF
Drug Master File, where available
When something is wrong with a batch
This is the part nobody asks about during the pitch and everybody needs when something goes wrong. The six steps below are the obligations of a GDP-certified distributor — Larissa holds GDP certificate No. 2881/GDP.
- 01
Receive and log
Every quality complaint is logged with the batch number, date received, the issue reported and the person who took it.
- 02
Trace the batch
From the batch number we trace back to the manufacturer, the receiving date, storage conditions and every customer that received it.
- 03
Quarantine
Any remaining stock is moved to the quarantine zone and held from dispatch until the investigation closes.
- 04
Escalate to the manufacturer
The complaint file goes to the manufacturer for reconciliation against the original certificate of analysis and the retained samples.
- 05
Recall where required
Where a recall is required, Larissa notifies every customer that received the batch and reports to the regulatory authority as required.
- 06
Close out and prevent
Root cause and corrective action are recorded and carried into the manufacturer's next re-qualification review.
Quality complaints and batch traceability requests are handled directly by the responsible pharmacist. See who to contact
